# Suzhou Singular Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-singular-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.singularmedical.net
- Total disclosed funding: $21M
- Latest round: Series C (Mar 12, 2025)
- Investors on record: 9

## About

Established in 2017 and based in Suzhou, China, Suzhou Singular Medical Co., Ltd. is a company that specializes in R&D, production, and sales of various types of cardiac products, including implantable cardioverter defibrillators, pacemakers, and implantable cardiac monitors. The company is headquartered in Suzhou and has R&D, lab and manufacturing centers in Beijing and Irvine and Minneapolis, with a team of over 70 employees in China and 30 in the US. It has filed 120 Chinese patents and 5 US patents as of 2023.  In March 2026, Suzhou Singular Medical Co., Ltd. raised a series C+ funding from Hunan Hi-Tech Venture Capital Investment Group.
The company's self-developed products such as implantable cardioverter defibrillator, implantable cardiac event monitor and, implantable cardiac defibrillation electrode lead. The implantable cardioverter defibrillator has the function of automatic recognition of malignant arrhythmias, release of anti-tachycardia pacing, and electric shock defibrillation.

Suzhou Singular Medical Co., Ltd. generates revenue by providing innovative CRM devices such as ICDs, ICMs, and pacemakers, alongside tailored clinical solutions and commercialization partnerships with healthcare institutions.

The series C+ round of financing will be used to accelerate the clinical advancement, registration, and commercialization of high-tech products such as ICDs.

## Funding rounds

- Series C, Mar 12, 2025, $21M — Qiming Venture Partners, SND Ventures Group, Tasly Capital Holdings Limited, HWealth Capital
- Series B, Jan 6, 2023 — Qiming Venture Partners, Lotus Lake Capital, Kangyu Fund
- Series B, Feb 19, 2021 — Qiming Venture Partners, NLVC, SND Ventures Group, Marathon Venture Partners, SDIC Unity Capital
- Series A, Mar 17, 2020 — Qiming Venture Partners, NLVC, SND Ventures Group, Marathon Venture Partners
- Angel, Jan 11, 2018 — NLVC

## Investors

- NLVC (https://capitalatlas.ai/funds/nlvc) — Angel, Series A, Series B
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B, Series C
- SND Ventures Group (https://capitalatlas.ai/funds/snd-ventures-group) — Series A, Series B, Series C
- Marathon Venture Partners (https://capitalatlas.ai/funds/marathon-venture-partners) — Series A, Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series B
- Kangyu Fund — Series B
- Tasly Capital Holdings Limited (https://capitalatlas.ai/funds/tasly-capital-holdings-limited) — Series C
- HWealth Capital (https://capitalatlas.ai/funds/hwealth-capital) — Series C